02/11/2016Finding a cure: Getting the best Brexit deal for Britain’s life sciencesFour months have now elapsed since the UK voted to leave the EU. The wholesale changes to the Share XFinding a cure: Getting the best Brexit deal for Britain’s life scienceshttps://pharmaphorum.com/debates-insight-market-access/finding-cure-getting-best-brexit-deal-britains-life-sciences/
Available on-demand: COPD, connecting real world needs to patient centric solutions COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and Share XAvailable on-demand: COPD, connecting real world needs to patient centric solutionshttps://pharmaphorum.com/debates-insight-patients/live-webinar-debate-feb-4th-copd-connecting-real-world-needs-to-patient-centric-solutions-price-is-right-uk-niche-market-access-2/
Available on-demand: The Price is Right? – Delivering UK access for niche patient populations With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what Share XAvailable on-demand: The Price is Right? – Delivering UK access for niche patient populationshttps://pharmaphorum.com/debates-insight-market-access/live-webinar-the-price-is-right-uk-niche-market-access/
